Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Berstein

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The AAPS Journal|May 24, 2017
Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and SkinCatherine Soderstrom, Gabriel Berstein, Weidong Zhang, et al.
Assay and Drug Development Technologies|January 21, 2010
A human CXCL13-induced actin polymerization assay measured by fluorescence plate readerJennifer Alley, Laird Bloom, Marion Kasaian, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Identification of a new class of small molecule C5a receptor antagonistsJack J Chen, Derek C Cole, Greg Ciszewski, et al.
The Journal of Investigative Dermatology|November 10, 2019
Early Quantification of Systemic Inflammatory Proteins Predicts Long-Term Treatment Response to Tofacitinib and EtanerceptLewis E Tomalin, Jaehwan Kim, Joel Correa da Rosa, et al.
Rheumatology (Oxford, England)|April 5, 2018
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritisDouglas J Veale, Dennis McGonagle, Iain B McInnes, et al.
The British Journal of Dermatology|March 27, 2023
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group studyMegan N Landis, Stacy R Smith, Gabriel Berstein, et al.
The Journal of Investigative Dermatology|September 21, 2017
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of TreatmentJaehwan Kim, Lewis Tomalin, Julie Lee, et al.
Pharmaceutical Research|December 29, 2023
Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig ModelManfred Bodenlenz, Thean Yeoh, Gabriel Berstein, et al.
Rheumatology (Oxford, England)|January 20, 2023
RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cellsCéline Mortier, Eric Gracey, Julie Coudenys, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistsMark E Schnute, John I Trujillo, Katherine L Lee, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The AAPS Journal|May 24, 2017
Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and SkinCatherine Soderstrom, Gabriel Berstein, Weidong Zhang, et al.
Assay and Drug Development Technologies|January 21, 2010
A human CXCL13-induced actin polymerization assay measured by fluorescence plate readerJennifer Alley, Laird Bloom, Marion Kasaian, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Identification of a new class of small molecule C5a receptor antagonistsJack J Chen, Derek C Cole, Greg Ciszewski, et al.
The Journal of Investigative Dermatology|November 10, 2019
Early Quantification of Systemic Inflammatory Proteins Predicts Long-Term Treatment Response to Tofacitinib and EtanerceptLewis E Tomalin, Jaehwan Kim, Joel Correa da Rosa, et al.
Rheumatology (Oxford, England)|April 5, 2018
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritisDouglas J Veale, Dennis McGonagle, Iain B McInnes, et al.
The British Journal of Dermatology|March 27, 2023
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group studyMegan N Landis, Stacy R Smith, Gabriel Berstein, et al.
The Journal of Investigative Dermatology|September 21, 2017
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of TreatmentJaehwan Kim, Lewis Tomalin, Julie Lee, et al.
Pharmaceutical Research|December 29, 2023
Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig ModelManfred Bodenlenz, Thean Yeoh, Gabriel Berstein, et al.
Rheumatology (Oxford, England)|January 20, 2023
RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cellsCéline Mortier, Eric Gracey, Julie Coudenys, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistsMark E Schnute, John I Trujillo, Katherine L Lee, et al.
Pageof 2